Literature DB >> 10762295

Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1.

N Hai1, N Aoki, A Shimatsu, T Mori, S Kosugi.   

Abstract

OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN1) is a familial tumour syndrome of endocrine tumours involving parathyroids, anterior pituitary and enteropancreatic neuroendocrine tissues, and is inherited in an autosomal dominant manner with high penetrance. Recently, the gene responsible for this syndrome, MEN1, was positionally cloned from chromosome 11q13. PATIENTS: To characterize sporadic MEN1 patients, we analysed the MEN1 gene by direct sequencing of the entire open reading frame from 20 individuals.
RESULTS: We identified heterozygous germline mutations of the MEN1 gene in 8 of 20 (40%) cases. Seven were novel MEN1 germline mutations. Three mutations were splicing abnormalities, and all were confirmed to be splicing defects by RT-PCR. The clinical significance of detecting germline MEN1 mutations, not only in familial MEN1 but also in sporadic MEN1, was confirmed by the finding of asymptomatic mutant carriers among family members of the sporadic MEN1 patients. Seven of 8 cases with MEN1 mutations had enteropancreatic lesions in contrast to 4 of 12 (P < 0.018) in those cases with no mutation. Ten of the 12 cases without MEN1 mutation were more than 50-year-old. Six of these 10 cases had the same clinical features; primary hyperparathyroidism and a GH-secreting pituitary tumour.
CONCLUSIONS: It is likely that the six cases without mutations were MEN1 phenocopies due to (i) two kinds of tumours with high natural incidence in older subjects developed by chance (ii) another familial tumour syndrome with low penetrance, e. g. familial acromegaly with primary hyperparathyroidism by mutation of another gene, or (iii) somatic mutation during early embryonic stages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762295     DOI: 10.1046/j.1365-2265.2000.00966.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  19 in total

1.  Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.

Authors:  Junko Naito; Hiroshi Kaji; Hideaki Sowa; Riko Kitazawa; Sohei Kitazawa; Toshihiko Tsukada; Geoffrey N Hendy; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 3.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 4.  The MEN1 gene and associated diseases: an update.

Authors:  T Tsukada; K Yamaguchi; T Kameya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.

Authors:  Francesca Marini; Francesca Giusti; Caterina Fossi; Federica Cioppi; Luisella Cianferotti; Laura Masi; Francesca Boaretto; Stefania Zovato; Filomena Cetani; Annamaria Colao; Maria Vittoria Davì; Antongiulio Faggiano; Giuseppe Fanciulli; Piero Ferolla; Diego Ferone; Paola Loli; Franco Mantero; Claudio Marcocci; Giuseppe Opocher; Paolo Beck-Peccoz; Luca Persani; Alfredo Scillitani; Fabiana Guizzardi; Anna Spada; Paola Tomassetti; Francesco Tonelli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2018-03-01       Impact factor: 3.633

6.  Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.

Authors:  Mutlu Niyazoglu; Muge Sayitoglu; Sinem Firtina; Esra Hatipoglu; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

7.  Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.

Authors:  V S Nunes; G L Souza; D Perone; S J Conde; C R Nogueira
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

8.  MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1.

Authors:  Rani Raghavan; Sudeep Shah; Altaf A Kondkar; Alpa J Dherai; Devendra Desai; Phulrenu Chauhan; Murad Lala; Tester F Ashavaid
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Isolated familial somatotropinomas: clinical and genetic considerations.

Authors:  Lawrence A Frohman
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

10.  Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.

Authors:  Marianthi Georgitsi; Anniina Raitila; Auli Karhu; Karoliina Tuppurainen; Markus J Mäkinen; Outi Vierimaa; Ralf Paschke; Wolfgang Saeger; Rob B van der Luijt; Timo Sane; Mercedes Robledo; Ernesto De Menis; Robert J Weil; Anna Wasik; Grzegorz Zielinski; Olga Lucewicz; Jan Lubinski; Virpi Launonen; Pia Vahteristo; Lauri A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.